FDA permits Dexcom Share, first mobile medical CGM app

Warning message

Could not find a Solr index corresponding to your website and environment. Your subscription contains these indexes: DQUY-108526.prod.bchoutreach, DQUY-108526.dev.medctrpharm, DQUY-108526.dev.controller, DQUY-108526.prod.healthworkforce, DQUY-108526.prod.rnworkforce, DQUY-108526.prod.medctrpharm, DQUY-108526.prod.controller, DQUY-108526.dev.pharmacy, DQUY-108526.prod.supplychain, DQUY-108526.test.controller, DQUY-108526.prod.itsm, DQUY-108526.prod.myapex, DQUY-108526.prod.osrintranet, DQUY-108526.dev.datacenter, DQUY-108526.dev.omfs, DQUY-108526.prod.software, DQUY-108526.prod.datacenter, DQUY-108526.prod.websites, DQUY-108526.prod.bchsfoutreach, DQUY-108526.prod.spmanual, DQUY-108526.prod.pharmacy, DQUY-108526.prod.depression_center, DQUY-108526.prod.provost. To fix this problem, please read our documentation.

The U.S. Food and Drug Administration today allowed marketing of the first set of mobile medical apps that allow people with diabetes to automatically and securely share data from a continuous glucose monitor (CGM) with other people in real-time using an Apple mobile device such as an iPhone. Check out the FDA press announcement about Dexcom Share. It works with the G4 Platinum.